3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Myelodysplastic Syndromes
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Leukemia, Myeloid, Acute
11
Multiple Myeloma
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Lymphoma, Non-Hodgkin
6
Lymphoma
6
Myeloproliferative Disorders
5
Hodgkin Disease
5
Leukemia, Myelomonocytic, Juvenile
4
Leukemia
4
Precancerous Conditions
3
Neoplasms, Plasma Cell
3
Lymphoma, Mantle-Cell
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Burkitt Lymphoma
3
Anemia, Aplastic
3
Waldenstrom Macroglobulinemia
2
Smoldering Multiple Myeloma
2
Recurrence
2
Primary Myelofibrosis
2
Preleukemia
2
Neoplasms by Histologic Type
2
Neoplasms
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
Vincristine
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Etoposide
1
Drug Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Retinal Neoplasms
×
Melphalan
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled